| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |